Myeloma care is evolving rapidly, with effective therapies now used earlier in the disease course and emerging options such as bispecific antibodies and CAR‑T reshaping later‑line treatment. As pathways become more complex and patients remain on therapy for longer, the role of nurses is increasingly critical. This session will explore key changes across the myeloma journey and the practical implications for nursing practice, including care coordination, monitoring tolerability, and supporting patient‑centred care.

Speakers coming soon!

INDUSTRY BREAKFAST | From First Line to CAR‑T: How Myeloma Care Is Evolving — and What It Means for Nurses

Session sponsor